Staying Slim, Fit Important For Cancer Survivors

 


WASHINGTON (Reuters, Nov. 30, 2006) - Staying slim and fit is especially important for cancer survivors because obesity raises the risk of cancer coming back, the American Cancer Society said in new guidelines issued in late November.
 
"The evidence really is quite strong for the need for cancer survivors to achieve and maintain a healthful weight," Wendy Demark-Wahnefried of Duke University Medical Center, one of the report's authors, said in an interview.

The recommendations, updating advice issued in 2001 and 2003, were published in the society's "CA: A Cancer Journal for Clinicians."

The report said obesity is a well-established risk factor for some of the most common forms of cancer, including breast cancer in post-menopausal women and cancers of the colon, esophagus, liver, gallbladder, pancreas, kidney, uterus, and prostate.

It also cited increasing evidence that being overweight raises the risk for recurrence and reduces likelihood of survival for many cancers.

Demark-Wahnefried said cancer survivors also face a greater risk of heart disease and diabetes, adding, "Obesity is a big risk factor for those diseases as well as second cancers."

The American Cancer Society said nearly two-thirds of U.S. cancer patients live more than five years after diagnosis, and more than 10 million Americans now alive have been diagnosed with cancer at some time in their lives.

The report said vegetarian diets can have many benefits because they tend to be low in saturated fat and high in fiber and vitamins.

"However, no direct evidence has determined whether consuming a vegetarian diet has any additional benefit for the prevention of cancer recurrence over an omnivorous diet high in vegetables, fruits, and whole grains, and low in red meats," the report stated.

The report noted that preliminary evidence indicates that for some types of cancer, one to three hours per week of exercise can cut the risk of cancer recurrence and death.

Reuters

Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 

Latest Urology News
Prostate cancer radiotherapy safe for HIV patients

December 1, 2008 — NEW YORK (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men. Treatment appears to have no long-term effect on CD4+ cell count or viral load.

Drug proves useful in hard-to-treat BPH: study

November 28, 2008 — NEW YORK (Reuters Health) - In men with an enlarged prostate who fail to respond to tamsulosin (brand name Flomax), treatment with the drug naftopidil may help alleviate common bothersome symptoms, such as having to make frequent nightly trips to the bathroom to urinate, research shows.

Cancer rates and cancer-related deaths drop in U.S.

November 25, 2008 — NEW YORK (Reuters Health) - For the first time ever, the overall cancer incidence and death rates have declined for men and women in the United States, according to an annual report released Tuesday by the American Cancer Society, the National Cancer Institute, and other groups.

Select news items provided by Reuters Health